IL6 and prostate cancer: Osteocalcin activation of GPRC6A may indirectly promote androgen synthesis through stimulation of IL-6 [10], a cytokine that can promote androgen synthesis in prostate cancer cells through enhancing AKR1C3 transcription [51].